Table of contents
Share Post
At Osra Medical, we’re always working to stay at the forefront of HIV prevention and PrEP treatment news so we can provide our patients the most up-to-date information. Today, we’re excited to share a significant development in the global fight against HIV/AIDS.
The World Health Organization (WHO) has announced plans to develop new guidelines for Gilead’s lenacapavir as a Pre-Exposure Prophylaxis (PrEP) option. This news brings the medical community one step closer to revolutionizing HIV prevention strategies worldwide.
Key Highlights of the WHO Announcement:
- The WHO will hold a virtual Guideline Development Group meeting from January 28-30, 2025, to establish guidelines for implementing lenacapavir as a PrEP regimen.
- The meeting will also focus on simplifying current and long-term HIV testing models.
- Specific objectives for this meeting include:
- “to evaluate the efficacy, safety, and acceptability of injectable lenacapavir as an additional PrEP option for populations at substantial risk of HIV infection, supporting a recommendation for its use within combination HIV prevention approaches;” and
- “to provide evidence-based guidance on HIV testing protocols for individuals using long-acting PrEP options, including lenacapavir, covering initiation, continuation, and discontinuation, with considerations for implementation in low-resource settings.”
What Makes Lenacapavir Special?
Lenacapavir is a groundbreaking HIV medication that targets the virus’s capsid, a protein layer that protects its DNA or RNA, preventing viral replication. While lenacapavir is currently approved in the United States for treating multi-drug-resistant HIV, its potential as a PrEP option is generating significant excitement in the medical community.
Recent clinical trials have shown promising results:
- The Purpose 1 trial demonstrated 100% efficacy in preventing HIV in cisgender women.
- The Purpose 2 trial showed a 99.9% efficacy rate and a 96% reduction in HIV cases.
These impressive outcomes led to Science Magazine naming lenacapavir the “Breakthrough Drug of the Year.”
What This Means for Our Patients
As a concierge medical practice, Osra Medical is committed to providing cutting-edge HIV prevention and treatment options to our patients. We’re thrilled about lenacapavir’s potential. If approved as a PrEP option, it could offer several benefits:
- Long-acting injectable delivery, potentially improving adherence
- Less frequent drug administration, reducing the frequency of doses
- High efficacy rates in preventing HIV transmission
Challenges and Considerations of HIV Prevention with Lenacapavir
While lenacapavir shows immense promise, it’s important to note that cost remains a significant barrier for many patients. However, Gilead is working on efforts to make the drug more accessible.
By signing royalty-free voluntary licensing agreements with six generic manufacturers, Gilead is allowing lenacapavir production in high-incidence countries. The countries covered by these agreements account for 70% of global HIV cases.
The upcoming WHO guidelines will be crucial in determining how lenacapavir can be implemented as a global PrEP option, especially in low-resource areas. At Osra Medical, we’re committed to staying informed about these developments and bringing the latest HIV prevention strategies to our patients in San Francisco and beyond.
Stay Informed with Osra Medical
We encourage our patients to engage in open discussions about PrEP and our team is here to answer any questions you may have about your HIV prevention strategy. As we await the WHO’s new guidelines and potential FDA approval of lenacapavir for PrEP, the Osra Medical team remains dedicated to offering the best available HIV prevention options to our patients.
At Osra Medical, we strive to provide concierge healthcare at its best, serving all members of our community with dignity, respect, and excellence. If you’re interested in becoming a member patient of Osra Medical, contact our team to book your introductory appointment with Dr. Nas Mohamed to learn more about how we can help you with primary care, tele-health, and a variety of other healthcare services.
Read our blog or sign up to our email list to stay tuned for more information from Osra Medical and ongoing updates as we work together towards more diverse and effective HIV prevention tools!